Erythema exsudativum multiforme infolge einer COVID-19-Impfung (BNT162b2)Erythema multiforme following COVID-19 vaccination (BNT162b2)

被引：0
|
作者：
K. Wunderlich
T. Dirschka
机构：
[1] CentroDerm Klinik Wuppertal,Fakultät für Gesundheit
[2] Universität Witten-Herdecke,undefined
来源：
Der Hautarzt | 2022年 / 73卷 / 1期
关键词：
Erythema exsudativum multiforme; COVID-19-Impfung; BNT162b2, Tozinameran; Hypersensitivitätsreaktion; Interface-Dermatitis; Erythema multiforme major; Coronavirus disease 2019 vaccination; BNT162b2, tozinameran; Hypersensitivity reaction; Interface dermatitis;
D O I：
10.1007/s00105-021-04911-4
中图分类号：
学科分类号：
摘要：
Es wird über den Fall eines ausgeprägten Erythema exsudativum multiforme infolge einer COVID-19-Impfung berichtet. Die Effloreszenzen an Haut und Schleimhaut entwickelten sich 48 h nach der zweiten Dosis des mRNA-Impfstoffs BNT162b2 (Tozinameran, Comirnaty®). Unter der Anwendung glukokortikoidhaltiger Externa kam es innerhalb von 3 Wochen zu einer folgenlosen Abheilung.
引用
收藏
页码：68 / 70
页数：2
相关论文
共 50 条
  • [31] Effectiveness of the BNT162b2 mRNA COVID-19 vaccine in pregnancy
    Noa Dagan
    Noam Barda
    Tal Biron-Shental
    Maya Makov-Assif
    Calanit Key
    Isaac S. Kohane
    Miguel A. Hernán
    Marc Lipsitch
    Sonia Hernandez-Diaz
    Ben Y. Reis
    Ran D. Balicer
    Nature Medicine, 2021, 27 : 1693 - 1695
  • [32] BNT162b2 Vaccine Booster and Mortality Due to Covid-19
    Arbel, Ronen
    Hammerman, Ariel
    Sergienko, Ruslan
    Friger, Michael
    Peretz, Alon
    Netzer, Doron
    Yaron, Shlomit
    NEW ENGLAND JOURNAL OF MEDICINE, 2021, 385 (26): : 2413 - 2420
  • [33] Spinal cord ischemia complicating BNT162b2 mRNA COVID-19 vaccination
    Fotiadou, Aggeliki
    Tsiptsios, Dimitrios
    Kitmeridou, Sofia
    Mavraki, Eleni
    Iliopoulos, Ioannis
    NEUROLOGICAL SCIENCES, 2023, 44 (02) : 457 - 459
  • [34] BNT162b2 mRNA Covid-19 Vaccine in a Nationwide Mass Vaccination Setting
    Dagan, Noa
    Barda, Noam
    Kepten, Eldad
    Miron, Oren
    Perchik, Shay
    Katz, Mark A.
    Hernan, Miguel A.
    Lipsitch, Marc
    Reis, Ben
    Balicer, Ran D.
    NEW ENGLAND JOURNAL OF MEDICINE, 2021, 384 (15): : 1412 - 1423
  • [35] BNT162b2 mRNA Covid-19 Vaccine - in a Nationwide Mass Vaccination Setting
    Roest, Stefan
    Hoek, Rogier A. S.
    Manintveld, Olivier C.
    NEW ENGLAND JOURNAL OF MEDICINE, 2021, 384 (20): : 1968 - 1970
  • [36] A Case of Immune Thrombocytopenia After BNT162b2 mRNA COVID-19 Vaccination
    King, Eleanor R.
    Towner, Elizabeth
    AMERICAN JOURNAL OF CASE REPORTS, 2021, 22
  • [37] Insulin allergy manifesting soon after COVID-19 vaccination (BNT162b2)
    Komamura, Hiroshi
    Kawana, Yohei
    Imai, Junta
    Katagiri, Hideki
    JOURNAL OF DIABETES INVESTIGATION, 2023, 14 (03) : 498 - 499
  • [38] A case of hemophagocytic lymphohistiocytosis after BNT162b2 COVID-19 (Comirnaty®) vaccination
    Shimada, Yoshitaka
    Nagaba, Yasushi
    Okawa, Hiroyuki
    Ehara, Kaori
    Okada, Shinya
    Yokomori, Hiroaki
    MEDICINE, 2022, 101 (43) : E31304
  • [39] Aseptic meningitis after vaccination of the BNT162b2 mRNA COVID-19 vaccine
    Saito, Kazuyuki
    Shimizu, Taro
    Suzuki-Inoue, Katsue
    Ishida, Tatsuhiro
    Wada, Yoshiaki
    NEUROLOGICAL SCIENCES, 2021, 42 (11) : 4433 - 4435
  • [40] Liver injury and cytopenia after BNT162b2 COVID-19 vaccination in an adolescent
    Kawasaki, Yu
    Matsubara, Kousaku
    Hori, Masayuki
    Isome, Kenichi
    PEDIATRICS INTERNATIONAL, 2022, 64 (01)
12345